Arxis Inc. (ARXS) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

Per the Roarable RQD rating, ARXS scores 72 out of 100 with a letter grade of B and a verdict label of "Roarable Buy — Good Risk/Reward." The five pillars are: Fundamental Cash Engine at 14/20 (ROIC 4%; FCF yield 0.76%), Whale 13F Flow at 17/20 (institutional accumulation and options positioning), Insider Conviction at 10/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13/20 (Beta 1.06; sector sensitivity), and Forensic Balance Sheet at 18/20 (Altman Z 4.58; Piotroski F 9/9; Debt/Equity 0.83).

For a prospective investor, the strongest pillars are the forensic balance sheet and institutional flow, which together point to a company whose accounting quality and ownership base are rated favorably. The weakest pillar is insider conviction, indicating less supporting evidence from insider or congressional trading. The cash-generation pillar is middling: the stated ROIC of 4% and FCF yield of 0.76% are modest relative to the valuation implied by an EV/EBITDA of 77.1, which is an upside-limiting tradeoff if growth does not accelerate. Macro fit is moderate, with a beta of 1.06 implying slightly above-market price sensitivity. The rating therefore describes a balance-sheet-strong, flow-supported name whose valuation and cash returns leave less margin for error.

Per the SEC financials, revenue grew from $424.5M in FY 2023 to $1591.0M in FY 2025, with net income turning positive in FY 2025 at $46.0M after losses in the prior two years. Per the Roarable RQD rating, the forensic balance sheet scores 18/20 with an Altman Z of 4.58 and a Piotroski F of 9/9, and the Debt/Equity ratio is 0.83 per the same rating. Reported ROIC is 4%, per Market Data. Debt has remained above $2.5B across all three periods, while FY 2025 free cash flow was $179.6M.

Per the recent news section, six items reference ARXS:

• A Yahoo Finance Singapore market-wire report (YELLOW) covering market action and institutional positioning.
• A CMC Markets piece (GREEN, CATALYST) questioning whether Arxis' acquisition engine can keep powering growth.
• A Yahoo Finance report (YELLOW) summarizing Q3 earnings.
• A MarketBeat report (YELLOW) citing a consensus target price of $54.64.
• A Stock Titan report (YELLOW) stating that up to 13.4M ARXS shares are covered for resale, with the company receiving no proceeds.
• A Quiver Quantitative report (YELLOW) on Q3 2026 earnings.

Risk watch items include the potential resale of up to 13.4M shares, which is a supply overhang source. The GREEN-tagged CMC item points to acquisition-driven growth as a catalyst, but the underlying figures are not in the source data. Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," no butterfly links exist, and no proprietary signals are recorded.

• What are Arxis' products, customers, and revenue drivers, given that the source data gives only sector and industry classification?
• What explains the swing from a FY 2024 net loss of $-55.5M to FY 2025 net income of $46.0M, and is it repeatable?
• Given debt of $2606.5M against cash of $250.3M in FY 2025, what is the refinancing and maturity profile?
• What EPS and forward earnings support the market price, since P/E and EPS are not available in source data?
• What is the scale and timing of the up to 13.4M share resale relative to total shares outstanding?